REGROW Act critique

Is REGROW Act anti-embryo research? Pluripotent stem cells excluded

REGROW-Act

The REGROW Act has attracted both support and criticism, including on this blog, for the changes it would mandate in the way the FDA regulates stem cell products. More specifically it would greatly reduce regulation of experimental stem cell products. I believe that would be dangerous to patients and to the stem cell field more …

Is REGROW Act anti-embryo research? Pluripotent stem cells excluded Read More »

Alliance for Regenerative Medicine (ARM) Opposes REGROW Act, Risks to Patients Cited

Alliance-for-Regenerative-Medicine

The biggest debate today in the stem cell world is over how much regulation is needed for new, investigational stem cell therapies that are not as yet approved. Sometimes it feels very lonely being out there publicly advocating for appropriately thorough regulation of stem cell therapies and at times I get a lot of heat for …

Alliance for Regenerative Medicine (ARM) Opposes REGROW Act, Risks to Patients Cited Read More »

REGROW Act is Attack on Science-Based Stem Cell Trial Oversight

REGROW-Act

Senators Mark Kirk, Joe Manchin, and Susan Collins have proposed new legislation in the form of the REGROW Act that would substantially interfere with the FDA’s ability to properly regulate the development of new stem cell and regenerative medicine therapies based on hard science. The REGROW Act would force the FDA to allow rushed introduction of experimental stem …

REGROW Act is Attack on Science-Based Stem Cell Trial Oversight Read More »